Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 10, 2001

View Archived Issues

MorphoSys Enters EUR22M Deal With Centocor Around HuCAL

SHIP2 Gene Makes Waves As Potential Type II Diabetes Target

European Parliament Report Calls For Separation Of Biotech Areas

Xantos Formed Around Platform To Perform Functional Genomics

GenOdyssee Applies For Patents Covering Genetic Variants Method

Other News To Note

MediGene's Genital Warts Drug Enters Phase III Clinical Trials

Combio Spun Off From Carlsberg To Develop Chemistry Platform

Oxford BioMedica Moving To LSE Following TroVax Trial Approval

Eurofins Beefing Up Detection Business Through Acquisitions

Phytopharm Sees Encouraging Results In Phase I P54 Study

PhotoCure Reports Skin Cancer Cures In Phase III PDT Trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...